Glucagon-like peptide-1 (GLP-1), a drug commonly used in treating diabetes and obesity, has also been shown to have ACSL4 inhibitory activity in MPTP-induced mice models [101]. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.